Real‐world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The <scp>LOTUS</scp> study

Publication Details

Journal
Developmental Medicine & Child Neurology
Published
2025-10-23
DOI
https://doi.org/10.1111/dmcn.70051
Primary Topic
Genetics and Neurodevelopmental Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real‐world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study

Developmental Medicine & Child Neurology
Genetics and Neurodevelopmental Disorders
article

Real‐world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study

article en

Abstract

No abstract available for this paper.
Developmental Medicine & Child NeurologyVol. 67(12)
Openalex Percentile: Top 67%
Genetics and Neurodevelopmental Disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Real‐world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The <scp>LOTUS</scp> study · Developmental Medicine & Child Neurology (2025) | TGRS Research Map | TGRS